Pyrazinamide - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for pyrazinamide and what is the scope of patent protection?

Pyrazinamide is the generic ingredient in one branded drug marketed by Hikma, Macleods Pharms Ltd, and Novitium Pharma, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for pyrazinamide. Eight suppliers are listed for this compound.

Summary for pyrazinamide

US Patents:	0
Tradenames:	1
Applicants:	3
NDAs:	3
Drug Master File Entries:	7
Finished Product Suppliers / Packagers:	8
Raw Ingredient (Bulk) Api Vendors:	152
Clinical Trials:	125
Patent Applications:	7,081
Drug Prices:	Drug price trends for pyrazinamide
What excipients (inactive ingredients) are in pyrazinamide?	pyrazinamide excipients list
DailyMed Link:	pyrazinamide at DailyMed

See drug prices for pyrazinamide

Recent Clinical Trials for pyrazinamide

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Christian Medical College, Vellore, India	Phase 3
Indian Council of Medical Research	Phase 3
Madras Medical College	Phase 3

See all pyrazinamide clinical trials

Pharmacology for pyrazinamide

Drug Class	Antimycobacterial

Medical Subject Heading (MeSH) Categories for pyrazinamide

Antitubercular Agents

Anatomical Therapeutic Chemical (ATC) Classes for pyrazinamide

J04AK	Other drugs for treatment of tuberculosis
J04A	DRUGS FOR TREATMENT OF TUBERCULOSIS
J04	ANTIMYCOBACTERIALS
J	Antiinfectives for systemic use

US Patents and Regulatory Information for pyrazinamide

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Macleods Pharms Ltd	PYRAZINAMIDE	pyrazinamide	TABLET;ORAL	212541-001	Jul 27, 2020	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Novitium Pharma	PYRAZINAMIDE	pyrazinamide	TABLET;ORAL	080157-001	Approved Prior to Jan 1, 1982	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Hikma	PYRAZINAMIDE	pyrazinamide	TABLET;ORAL	081319-001	Jun 30, 1992	AB	RX	No	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.